The Net Margin of Celyad Oncology SA (CYAD.BR) is -3131.18%.
Net Margin measures the percentage of net income derived from total revenue after all expenses. It signals how much actual profit a company retains from its sales.
| Date | Value |
|---|---|
| 2024-12-31 | -3131.18% |
| 2023-12-31 | -8282.35% |
| 2022-12-31 | -344080.00% |
| 2021-12-31 | -477200.00% |
| 2020-12-31 | -1201.51% |
| 2019-12-31 | -1593.08% |
| 2018-12-31 | -276.97% |
| 2017-12-31 | -970466.70% |